Markers of gluten sensitivity in acute mania: A longitudinal study

Faith Dickerson, Cassie Stallings, Andrea Origoni, Crystal Vaughan, Sunil Khushalani, Robert H Yolken

Research output: Contribution to journalArticle

Abstract

Increased levels of antibodies to gliadin, which is derived from the wheat protein gluten, have been reported in schizophrenia and bipolar disorder in cross-sectional studies. We examined longitudinally the levels of antibody reactivity to gliadin in acute mania. The sample included 60 individuals assessed during a hospital stay for acute mania, 39 at a 6-month follow-up, and a sample of 143 non-psychiatric controls. Antibodies to gliadin were measured by enzyme immunoassay. The relationship of the antibodies to the clinical course of mania was analyzed by the use of regression models. Individuals with mania had significantly increased levels of IgG antibodies to gliadin, but not other markers of celiac disease, at baseline compared with controls in multivariate analyses. However, these levels were not significantly different from those of controls at the six month follow-up. Among the individuals with mania, elevated levels at follow-up were significantly associated with re-hospitalization in the 6-month follow-up period. The monitoring and control of gluten sensitivity may have significant effects on the management of individuals hospitalized with acute mania.

Original languageEnglish (US)
Pages (from-to)68-71
Number of pages4
JournalPsychiatry Research
Volume196
Issue number1
DOIs
StatePublished - Mar 30 2012

Fingerprint

Glutens
Bipolar Disorder
Longitudinal Studies
Gliadin
Antibodies
Celiac Disease
Immunoenzyme Techniques
Triticum
Length of Stay
Schizophrenia
Hospitalization
Multivariate Analysis
Cross-Sectional Studies
Immunoglobulin G

Keywords

  • Bipolar disorder
  • Gliadin antibody
  • Maria

ASJC Scopus subject areas

  • Psychiatry and Mental health
  • Biological Psychiatry

Cite this

Markers of gluten sensitivity in acute mania : A longitudinal study. / Dickerson, Faith; Stallings, Cassie; Origoni, Andrea; Vaughan, Crystal; Khushalani, Sunil; Yolken, Robert H.

In: Psychiatry Research, Vol. 196, No. 1, 30.03.2012, p. 68-71.

Research output: Contribution to journalArticle

Dickerson, F, Stallings, C, Origoni, A, Vaughan, C, Khushalani, S & Yolken, RH 2012, 'Markers of gluten sensitivity in acute mania: A longitudinal study', Psychiatry Research, vol. 196, no. 1, pp. 68-71. https://doi.org/10.1016/j.psychres.2011.11.007
Dickerson, Faith ; Stallings, Cassie ; Origoni, Andrea ; Vaughan, Crystal ; Khushalani, Sunil ; Yolken, Robert H. / Markers of gluten sensitivity in acute mania : A longitudinal study. In: Psychiatry Research. 2012 ; Vol. 196, No. 1. pp. 68-71.
@article{4849007b85f54be7b71039bea22b69e8,
title = "Markers of gluten sensitivity in acute mania: A longitudinal study",
abstract = "Increased levels of antibodies to gliadin, which is derived from the wheat protein gluten, have been reported in schizophrenia and bipolar disorder in cross-sectional studies. We examined longitudinally the levels of antibody reactivity to gliadin in acute mania. The sample included 60 individuals assessed during a hospital stay for acute mania, 39 at a 6-month follow-up, and a sample of 143 non-psychiatric controls. Antibodies to gliadin were measured by enzyme immunoassay. The relationship of the antibodies to the clinical course of mania was analyzed by the use of regression models. Individuals with mania had significantly increased levels of IgG antibodies to gliadin, but not other markers of celiac disease, at baseline compared with controls in multivariate analyses. However, these levels were not significantly different from those of controls at the six month follow-up. Among the individuals with mania, elevated levels at follow-up were significantly associated with re-hospitalization in the 6-month follow-up period. The monitoring and control of gluten sensitivity may have significant effects on the management of individuals hospitalized with acute mania.",
keywords = "Bipolar disorder, Gliadin antibody, Maria",
author = "Faith Dickerson and Cassie Stallings and Andrea Origoni and Crystal Vaughan and Sunil Khushalani and Yolken, {Robert H}",
year = "2012",
month = "3",
day = "30",
doi = "10.1016/j.psychres.2011.11.007",
language = "English (US)",
volume = "196",
pages = "68--71",
journal = "Psychiatry Research",
issn = "0165-1781",
publisher = "Elsevier Ireland Ltd",
number = "1",

}

TY - JOUR

T1 - Markers of gluten sensitivity in acute mania

T2 - A longitudinal study

AU - Dickerson, Faith

AU - Stallings, Cassie

AU - Origoni, Andrea

AU - Vaughan, Crystal

AU - Khushalani, Sunil

AU - Yolken, Robert H

PY - 2012/3/30

Y1 - 2012/3/30

N2 - Increased levels of antibodies to gliadin, which is derived from the wheat protein gluten, have been reported in schizophrenia and bipolar disorder in cross-sectional studies. We examined longitudinally the levels of antibody reactivity to gliadin in acute mania. The sample included 60 individuals assessed during a hospital stay for acute mania, 39 at a 6-month follow-up, and a sample of 143 non-psychiatric controls. Antibodies to gliadin were measured by enzyme immunoassay. The relationship of the antibodies to the clinical course of mania was analyzed by the use of regression models. Individuals with mania had significantly increased levels of IgG antibodies to gliadin, but not other markers of celiac disease, at baseline compared with controls in multivariate analyses. However, these levels were not significantly different from those of controls at the six month follow-up. Among the individuals with mania, elevated levels at follow-up were significantly associated with re-hospitalization in the 6-month follow-up period. The monitoring and control of gluten sensitivity may have significant effects on the management of individuals hospitalized with acute mania.

AB - Increased levels of antibodies to gliadin, which is derived from the wheat protein gluten, have been reported in schizophrenia and bipolar disorder in cross-sectional studies. We examined longitudinally the levels of antibody reactivity to gliadin in acute mania. The sample included 60 individuals assessed during a hospital stay for acute mania, 39 at a 6-month follow-up, and a sample of 143 non-psychiatric controls. Antibodies to gliadin were measured by enzyme immunoassay. The relationship of the antibodies to the clinical course of mania was analyzed by the use of regression models. Individuals with mania had significantly increased levels of IgG antibodies to gliadin, but not other markers of celiac disease, at baseline compared with controls in multivariate analyses. However, these levels were not significantly different from those of controls at the six month follow-up. Among the individuals with mania, elevated levels at follow-up were significantly associated with re-hospitalization in the 6-month follow-up period. The monitoring and control of gluten sensitivity may have significant effects on the management of individuals hospitalized with acute mania.

KW - Bipolar disorder

KW - Gliadin antibody

KW - Maria

UR - http://www.scopus.com/inward/record.url?scp=84860625865&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84860625865&partnerID=8YFLogxK

U2 - 10.1016/j.psychres.2011.11.007

DO - 10.1016/j.psychres.2011.11.007

M3 - Article

C2 - 22386570

AN - SCOPUS:84860625865

VL - 196

SP - 68

EP - 71

JO - Psychiatry Research

JF - Psychiatry Research

SN - 0165-1781

IS - 1

ER -